|
| |
|
(b) | any person otherwise than in the course of carrying on a |
| |
| |
(3) | A “chargeable trade” is— |
| |
(a) | a trade, profession or vocation carried on wholly or partly in |
| |
the United Kingdom, the profits of which are chargeable to |
| 5 |
income tax under Chapter 2 of Part 2 of ITTOIA 2005, or |
| |
(b) | a trade carried on wholly or partly in the United Kingdom, |
| |
the profits of which are chargeable to corporation tax under |
| |
| |
(4) | Condition B is that the expenditure is expenditure to which section |
| 10 |
| |
104D | Expenditure on sub-contracted R&D undertaken in-house |
| |
(1) | This section applies to expenditure on research and development |
| |
contracted out to a company if conditions A, B and C are met. |
| |
(2) | Condition A is that the research and development is undertaken by |
| 15 |
| |
(3) | Condition B is that the expenditure is— |
| |
(a) | incurred on staffing costs (see section 1123), |
| |
(b) | incurred on software or consumable items (see section 1125), |
| |
(c) | qualifying expenditure on externally provided workers (see |
| 20 |
| |
(d) | incurred on relevant payments to the subjects of a clinical |
| |
trial (see section 1140). |
| |
(4) | Condition C is that the expenditure is attributable to relevant |
| |
research and development in relation to the company. |
| 25 |
(5) | See sections 1124, 1126 and 1132 for provision about when |
| |
expenditure within subsection (3)(a), (b) or (c) is attributable to |
| |
relevant research and development. |
| |
104E | Expenditure on sub-contracted R&D not undertaken in-house |
| |
(1) | This section applies to expenditure on research and development |
| 30 |
contracted out to a company if conditions A, B and C are met. |
| |
(2) | Condition A is that the expenditure is incurred in making payments |
| |
| |
| |
| 35 |
(c) | a firm, each member of which is an individual, |
| |
| in respect of research and development contracted out by the |
| |
company to the body, individual or firm. |
| |
(3) | Condition B is that the research and development is undertaken by |
| |
the body, individual or firm itself. |
| 40 |
(4) | Condition C is that the expenditure is attributable to relevant |
| |
research and development in relation to the company. |
| |
|
| |
|
| |
|
(5) | See sections 1124, 1126 and 1132 for provision about when particular |
| |
kinds of expenditure are attributable to relevant research and |
| |
| |
SMEs: subsidised qualifying expenditure |
| |
104F | Subsidised qualifying expenditure |
| 5 |
| For the purposes of this Chapter a company’s “subsidised qualifying |
| |
| |
(a) | its subsidised qualifying expenditure on in-house direct |
| |
research and development (see section 104G), and |
| |
(b) | its subsidised qualifying expenditure on contracted out |
| 10 |
research and development (see section 104H). |
| |
104G | Subsidised qualifying expenditure on in-house direct R&D |
| |
(1) | A company’s “subsidised qualifying expenditure on in-house direct |
| |
research and development” means expenditure incurred by it in |
| |
relation to which each of conditions A to D is met. |
| 15 |
(2) | Condition A is that the expenditure is subsidised. |
| |
(3) | Condition B is that the expenditure is— |
| |
(a) | incurred on staffing costs (see section 1123), |
| |
(b) | incurred on software or consumable items (see section 1125), |
| |
(c) | qualifying expenditure on externally provided workers (see |
| 20 |
| |
(d) | incurred on relevant payments to the subjects of a clinical |
| |
trial (see section 1140). |
| |
(4) | Condition C is that the expenditure is attributable to relevant |
| |
research and development undertaken by the company itself. |
| 25 |
(5) | Condition D is that the expenditure is not incurred by the company |
| |
in carrying on activities which are contracted out to the company by |
| |
| |
(6) | See sections 1124, 1126 and 1132 for provision about when |
| |
expenditure within subsection (3)(a), (b) or (c) is attributable to |
| 30 |
relevant research and development. |
| |
104H | Subsidised qualifying expenditure on contracted out R&D |
| |
(1) | A company’s “subsidised qualifying expenditure on contracted out |
| |
research and development” means expenditure— |
| |
(a) | which is incurred by it in making the qualifying element of a |
| 35 |
sub-contractor payment (see sections 1134 to 1136), and |
| |
(b) | in relation to which each of conditions A to E is met. |
| |
(2) | Condition A is that the expenditure is subsidised. |
| |
(3) | Condition B is that the sub-contractor is— |
| |
| 40 |
| |
(c) | a firm, each member of which is an individual. |
| |
|
| |
|
| |
|
(4) | Condition C is that the body, individual or firm concerned |
| |
undertakes the contracted out research and development itself. |
| |
(5) | Condition D is that the expenditure is attributable to relevant |
| |
research and development in relation to the company. |
| |
(6) | Condition E is that the expenditure is not incurred by the company |
| 5 |
in carrying on activities which are contracted out to the company by |
| |
| |
(7) | See sections 1124, 1126 and 1132 for provision about when particular |
| |
kinds of expenditure are attributable to relevant research and |
| |
| 10 |
SMEs: capped R&D expenditure |
| |
104I | Capped R&D expenditure |
| |
| For the purposes of this Chapter a company’s “capped R&D |
| |
expenditure” means any expenditure— |
| |
(a) | in respect of which the company is not entitled to relief under |
| 15 |
Chapter 2 of Part 13 merely because of section 1113 (cap on |
| |
| |
(b) | which is not qualifying expenditure on sub-contracted R&D, |
| |
| |
(c) | which would have been qualifying R&D expenditure had the |
| 20 |
company been a large company throughout the accounting |
| |
| |
Large companies: qualifying R&D expenditure |
| |
104J | Qualifying expenditure on in-house direct R&D |
| |
(1) | A company’s “qualifying expenditure on in-house direct research |
| 25 |
and development” means expenditure incurred by it in relation to |
| |
which conditions A, B and C are met. |
| |
(2) | Condition A is that the expenditure is— |
| |
(a) | incurred on staffing costs (see section 1123), |
| |
(b) | incurred on software or consumable items (see section 1125), |
| 30 |
(c) | qualifying expenditure on externally provided workers (see |
| |
| |
(d) | incurred on relevant payments to the subjects of a clinical |
| |
trial (see section 1140). |
| |
(3) | Condition B is that the expenditure is attributable to relevant |
| 35 |
research and development undertaken by the company itself. |
| |
(4) | Condition C is that, if the expenditure is incurred in carrying on |
| |
activities contracted out to the company, the activities are contracted |
| |
| |
| 40 |
(b) | any person otherwise than in the course of carrying on a |
| |
| |
(5) | A “chargeable trade” is— |
| |
|
| |
|
| |
|
(a) | a trade, profession or vocation carried on wholly or partly in |
| |
the United Kingdom, the profits of which are chargeable to |
| |
income tax under Chapter 2 of Part 2 of ITTOIA 2005, or |
| |
(b) | a trade carried on wholly or partly in the United Kingdom, |
| |
the profits of which are chargeable to corporation tax under |
| 5 |
| |
(6) | See sections 1124, 1126 and 1132 for provision about when |
| |
expenditure within subsection (2)(a), (b) or (c) is attributable to |
| |
relevant research and development. |
| |
104K | Qualifying expenditure on contracted out R&D |
| 10 |
(1) | A company’s “qualifying expenditure on contracted out research |
| |
and development” means expenditure incurred by it in relation to |
| |
which each of conditions A to D is met. |
| |
(2) | Condition A is that the expenditure is incurred in making payments |
| |
| 15 |
| |
| |
(c) | a firm, each member of which is an individual, |
| |
| in respect of research and development contracted out by the |
| |
company to the body, individual or firm concerned (“the contracted |
| 20 |
| |
(3) | Condition B is that the body, individual or firm concerned |
| |
undertakes the contracted out R&D itself. |
| |
(4) | Condition C is that the expenditure is attributable to relevant |
| |
research and development in relation to the company. |
| 25 |
(5) | Condition D is that, if the contracted out R&D is itself contracted out |
| |
to the company, it is contracted out by— |
| |
| |
(b) | any person otherwise than in the course of carrying on a |
| |
| 30 |
(6) | A “chargeable trade” is— |
| |
(a) | a trade, profession or vocation carried on wholly or partly in |
| |
the United Kingdom, the profits of which are chargeable to |
| |
income tax under Chapter 2 of Part 2 of ITTOIA 2005, or |
| |
(b) | a trade carried on wholly or partly in the United Kingdom, |
| 35 |
the profits of which are chargeable to corporation tax under |
| |
| |
(7) | See sections 1124, 1126 and 1132 for provision about when particular |
| |
kinds of expenditure are attributable to relevant research and |
| |
| 40 |
104L | Qualifying expenditure on contributions to independent R&D |
| |
(1) | A company’s “qualifying expenditure on contributions to |
| |
independent research and development” means expenditure |
| |
incurred by it in relation to which each of conditions A to E is met. |
| |
(2) | Condition A is that the expenditure is incurred in making payments |
| 45 |
| |
|
| |
|
| |
|
| |
| |
(c) | a firm, each member of which is an individual, |
| |
| for the purpose of funding research and development carried on by |
| |
the body, individual or firm concerned (“the funded R&D”). |
| 5 |
(3) | Condition B is that the funded R&D is relevant research and |
| |
development in relation to the company. |
| |
(4) | Condition C is that the funded R&D is not contracted out to the |
| |
qualifying body, individual or firm concerned by another person. |
| |
(5) | Condition D is that, if the payment is made to an individual, the |
| 10 |
company is not connected with the individual when the payment is |
| |
| |
(6) | Condition E is that, if the payment is made to a firm (other than a |
| |
qualifying body), the company is not connected with any member of |
| |
the firm when the payment is made. |
| 15 |
| |
104M | Amount of R&D expenditure credit |
| |
(1) | The amount of the R&D expenditure credit to which a company is |
| |
entitled for an accounting period is the relevant percentage of the |
| |
amount of the company’s qualifying R&D expenditure for the |
| 20 |
| |
(2) | In the case of a ring fence trade, the relevant percentage is 49%. |
| |
| In this subsection “ring fence trade” has the meaning given by |
| |
| |
(3) | In any other case, the relevant percentage is 10%. |
| 25 |
(4) | The Treasury may by order replace the percentage for the time being |
| |
specified in subsection (2) or (3) with a different percentage. |
| |
(5) | An order under subsection (4) may contain incidental, supplemental, |
| |
consequential and transitional provision and savings. |
| |
| 30 |
104N | Payment of R&D expenditure credit |
| |
(1) | This section applies if a company is entitled to an R&D expenditure |
| |
credit for an accounting period under this Chapter. |
| |
(2) | The amount to which the company is entitled in respect of the R&D |
| |
expenditure credit (“the set-off amount”) is to be treated in the |
| 35 |
| |
| |
| The set-off amount is to be applied in discharging any liability of the |
| |
company to pay corporation tax for the accounting period. |
| |
| If any of the set-off amount is remaining, go to step 2. |
| 40 |
| |
|
| |
|
| |
|
| If the amount remaining after step 1 is greater than the company’s |
| |
total expenditure on workers for the accounting period (see section |
| |
| |
(a) | that amount is to be reduced to the amount of that |
| |
expenditure (which may be nil), and |
| 5 |
(b) | so much of the amount remaining after step 1 as is greater |
| |
than the amount of that expenditure is to be treated for the |
| |
purposes of this section as an amount of R&D expenditure |
| |
credit to which the company is entitled for its next accounting |
| |
| 10 |
| If any of the set-off amount is remaining, go to step 3. |
| |
| |
| The amount remaining after step 2 is to be applied in discharging any |
| |
liability of the company to pay corporation tax for any other |
| |
| 15 |
| If any of the set-off amount is remaining, go to step 4. |
| |
| |
| If the company is a member of a group, it may surrender the whole |
| |
or any part of the amount remaining after step 3 to any other member |
| |
of the group (see section 104Q). |
| 20 |
| If no such surrender is made, or any of the set-off amount is |
| |
otherwise remaining, go to step 5. |
| |
| |
| Deduct from the amount remaining after step 4 the following |
| |
| 25 |
(a) | an amount equal to the corporation tax that would be |
| |
chargeable on the amount if it was an amount of profits (or in |
| |
the case of a ring fence trade, ring fence profits) of the |
| |
company for the accounting period and corporation tax on |
| |
such profits was chargeable at the main rate, and |
| 30 |
(b) | in the case of a ring fence trade, an amount equal to the |
| |
supplementary charge that would be chargeable on the |
| |
amount if it was an amount of adjusted ring fence profits for |
| |
| |
| For provision about the treatment of any amount so deducted, see |
| 35 |
| |
| |
| The amount remaining after step 5 is to be applied in discharging any |
| |
other liability of the company to pay a sum to the Commissioners |
| |
under or by virtue of an enactment or under a contract settlement. |
| 40 |
| If any of the set-off amount is remaining, go to step 7. |
| |
| |
| The amount remaining after step 6 is payable to the company by an |
| |
officer of Revenue and Customs. |
| |
| But this is subject to section 104S (restrictions on payment of R&D |
| 45 |
| |
|
| |
|
| |
|
| |
“adjusted ring fence profits” has the meaning given by section |
| |
| |
“the Commissioners” means the Commissioners for Her |
| |
Majesty’s Revenue and Customs, |
| 5 |
“contract settlement” means an agreement made in connection |
| |
with any person’s liability to make a payment to the |
| |
Commissioners under or by virtue of an enactment, |
| |
“ring fence profits” has the meaning given by section 276 of |
| |
| 10 |
“ring fence trade” has the meaning given by section 277 of CTA |
| |
| |
104O | Total expenditure on workers |
| |
(1) | For the purposes of section 104N, the amount of a company’s total |
| |
expenditure on workers for an accounting period is the sum of— |
| 15 |
(a) | the relevant portion of the company’s staffing costs for the |
| |
period (see subsection (2)), and |
| |
(b) | if the company is a member of a group and has incurred |
| |
expenditure on any externally provided workers, the |
| |
relevant portion of any staffing costs for the period incurred |
| 20 |
by another member of the group (the “relevant group |
| |
company”) in providing any of those workers for the |
| |
company (see subsection (3)). |
| |
(2) | The relevant portion of the company’s staffing costs for an |
| |
accounting period is the amount of those costs that— |
| 25 |
(a) | are paid to, or in respect of, directors or employees who are |
| |
directly and actively engaged in relevant research and |
| |
development (whether they are wholly or partly so engaged), |
| |
| |
(b) | form part of the total amount of the company’s PAYE and |
| 30 |
NIC liabilities for the accounting period (see section 104P). |
| |
(3) | The relevant portion of any staffing costs for an accounting period |
| |
incurred by a relevant group company in providing externally |
| |
provided workers for the company is the sum of the amounts to be |
| |
determined in the case of each of those workers as follows— |
| 35 |
| |
| Calculate the amount of expenditure that— |
| |
(a) | has been incurred by the relevant group company in |
| |
providing the externally provided worker for the company, |
| |
(b) | has been incurred on staffing costs, and |
| 40 |
(c) | forms part of the total amount of the relevant group |
| |
company’s PAYE and NIC liabilities for the accounting |
| |
period (see section 104P). |
| |
| |
| Calculate the percentage (the “appropriate percentage”) given by—![equation: cross[over[char[R],char[T]],num[100.0000000000000000,"100"]]](missing.gif) |
| 45 |
|
| |
|